Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate.
作者信息
Roe D A
出版信息
Arch Dermatol. 1968 Apr;97(4):436-45.
PMID:5643239
Abstract
摘要
相似文献
1
Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate.
Arch Dermatol. 1968 Apr;97(4):436-45.
2
Xanthomatosis and hyperlipoproteinemia; a review.黄瘤病和高脂蛋白血症；综述
Dermatologica. 1974;149(1):1-9.
3
Xanthomatosis associated with hyperlipoproteinemia.
J Invest Dermatol. 1970 Aug;55(2):71-88. doi: 10.1111/1523-1747.ep12291505.
4
Cholestyramine in type II hyperlipoproteinemia. A double-blind trial.消胆胺治疗II型高脂蛋白血症：一项双盲试验
Ann Intern Med. 1973 Jul;79(1):51-8. doi: 10.7326/0003-4819-79-1-51.
5
[Therapy of primary hyperlipemia].
Dtsch Med Wochenschr. 1971 May 7;96(19):831-2. doi: 10.1055/s-0028-1108342.
6
Treatment of essential hyperlipidaemia.
Lancet. 1970 Jan 24;1(7639):191-2. doi: 10.1016/s0140-6736(70)90430-7.
7
8
Treatment of essential hyperlipidaemia.
Lancet. 1969 Dec 20;2(7634):1315-9. doi: 10.1016/s0140-6736(69)90860-5.
9
[Serum-lipid reducing principles--possibilities for treatment. 7. Ion exchangers (cholestyramine)].
Lakartidningen. 1970 Dec 14;67:Suppl IV:83+.
10
[Homozygous cutaneo-tendinous forms of hypercholesteremic xanthomatosis in an exemplary familial case. Trial of plasmapheresis ans heroic treatment].
Bull Mem Soc Med Hop Paris. 1967 Dec 15;118(15):1377-402.
Zotero 插件